Sourced from:Direct from Manufacturer
Quick Summary
Irny 1000mg Injection
Last updated on 05 Aug 2026 | 06:49 AM (IST)
₹2887
MRP: ₹3969
(You Save ₹1082)
1 VIAL(s) OF 20ML
Sourced from:Direct from Manufacturer
Irny 1000mg Injection
Salt Composition
FERRIC CARBOXYMALTOSEMarketer
DR REDDY'S LABORATORIES LTD
27% OFF
₹2887
MRP: ₹3,969.00
Inclusive of all taxes
27% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Nefcm 1000mg Injection
ERIS LIFESCIENC...
₹ 1137.00/injection
60% cheaper
Fanemia 1000mg Injection
ERIS LIFESCIENC...
₹ 1252.00/injection
56% cheaper
Redshot FCM 1000mg Injection
CADILA PHARMACE...
₹ 2587.00/injection
10% cheaper
Glenferr FCM 1K Injection
GLENMARK PHARMA...
₹ 2876.00/injection
0% cheaper
Introduction to Irny 1000mg Injection
Irny 1000mg injection contains the active substance Ferric carboxymaltose. It belongs to the group of medications called iron replacement products. It is used to treat iron-deficiency anemia (decreased RBC due to lower levels of iron in the body) in adults and pediatric patients who cannot tolerate oral iron or when oral iron supplements are ineffective. It is also indicated to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis. This medicine is not recommended for pediatric patients less than one year of age.
Do not take this medicine if you are allergic to ferric carboxymaltose or any of the other ingredients of this medicine. Do not receive Irny 1000mg injection if you have anemia that is not caused by iron deficiency, an iron overload (too much iron in the body), or difficulties in using iron. Inform your physician if you have rheumatoid arthritis, severe asthma, eczema, infection, liver disorders, or low phosphate levels in the blood. Incorrect administration of this injection may cause irritation and long-lasting discoloration at the administration site.
Inform your physician if you are pregnant or breastfeeding before initiating the treatment with Irny 1000mg injection. The most common side effects are nausea, hypertension, flushing, injection site reactions, skin reactions, vomiting, and dizziness. Tell your physician if you have experienced serious allergic (hypersensitive) reactions to other injectable iron preparations.
Uses of Irny 1000mg Injection
- Iron deficiency anemia in adult and pediatric patients
- Treat iron deficiency anemia in adults with chronic kidney failure
Therapeutic Effects of Irny 1000mg Injection
Irny 1000mg injection releases iron via a carbohydrate polymer complexed with colloidal iron (III) hydroxide. This works by replenishing iron stores so that the body can make more red blood cells.
Interaction of Irny 1000mg Injection with other drugs
Inform your healthcare provider about all the medicines you take or have taken before, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications interact with Irny 1000mg injection and reduce their effectiveness by causing undesirable side effects.
More Information about Irny 1000mg Injection
- Do not store above 30°C
- Do not freeze
- Protect the medicine from light and excessive moisture.
- Keep the medicine out of reach of children and pets
- If you forgot to take the injection, inform your healthcare professional immediately and reschedule the appointment.
How to consume Irny 1000mg Injection
Irny 1000mg injection is an intravenously administered prescription drug. This injection will be given to you in a hospital or clinic setting. Your doctor will decide the dose, duration, and frequency of the administration based on your condition and other factors. Your doctor may perform a blood test to determine how much medicine you need. You will be completely observed by your doctor or other healthcare professional while administering the medicine. Do not self-administer the medicine.
Safety Advice for Irny 1000mg Injection
Breast Feeding
If you are a breastfeeding mother, consult your doctor before receiving Irny 1000mg injection injection.
Alcohol
It is not known whether it is safe to drink alcohol while receiving Irny 1000mg injection. Consult your doctor for more advice.
Liver
Irny 1000mg injection should be cautiously administered in patients with liver problems. Dose adjustments are necessary if you have liver problems. Inform your physician if you have any liver disease before initiating the therapy.
Lungs
It is unknown whether Irny 1000mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Driving
Irny 1000mg injection does not alter your ability to drive and operate heavy machinery. If you feel dizzy, consult the doctor before driving or using machines.
Pregnancy
There is limited data available for the use of Irny 1000mg injection during pregnancy. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment.
Side Effects of Irny 1000mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common
- Skin reactions
- Flushing
- Injection site reactions
- Decreased phosphate levels
- Nausea, Vomiting
- Headache, dizziness
Serious
- Increased blood pressure
- Hypersensitivity reactions
- Increased phosphate levels
Word of Advice
Inform your physician if you have high blood pressure because this medicine may cause high blood pressure. Your doctor may suggest you to take certain tests before giving this medicine to determine the iron levels in your body. Tell your doctor if you experience any of these following signs and symptoms that may indicate a serious allergic reaction (hypersensitivity reactions) such as rash, itching, difficulty breathing, wheezing, swelling of the lips or mouth, and chest pain.
FAQs about Irny 1000mg Injection
Q1.
What are the rare side effects of Irny 1000mg injection?
The rare side effects of Irny 1000mg injection, which affects 1 in 1000 people, are inflammation of the veins, anxiety, fainting, wheezing, flatulence, and rapid swelling of the face, mouth, tongue, or throat, which may cause difficulty in breathing, paleness, and skin discoloration at other areas of the body than the administration site.
Q2.
Can Irny 1000mg injection be used in pediatric patients?
Yes, Irny 1000mg injection is used in pediatric patients one year and older to treat iron deficiency anemia.
Q3.
Does Irny 1000mg injection require any special storage conditions?
Irny 1000mg injection should not be stored more than 30°C, away from light and moisture. It should be kept out of reach of children and pets. It is important to follow the storage instructions provided with the medication.
Q4.
Will I be monitored during this treatment?
You will be monitored for 30 minutes for signs of an allergic reaction after injecting Irny 1000mg injection. Your healthcare provider will also monitor your blood pressure and phosphate levels during this treatment.
Q5.
Is it safe for women of reproductive potential to use Irny 1000mg injection?
Only limited information is available on the use of Irny 1000mg injection during pregnancy because the risk of hypersensitivity reactions can have serious consequences on the fetus. However, it is unknown whether this medicine would pose a risk to your baby. Tell your healthcare provider before taking this injection if you are pregnant, think you could be pregnant, breastfeeding, or planning to have a baby.
Fact Box of Irny 1000mg Injection
Molecule Name: Ferric carboxymaltose | Therapeutic Class: Hematopoietic agents |
Pharmacological Class: Iron replacement products | Indications: 1. Iron deficiency anemia in adults and pediatric patients 2. Treat iron deficiency anemia in adults with chronic kidney failure |
References
- Highlights Of Prescribing Information - Ferric carboxymaltose access.fda.gov. [Revised 2022 Feb] [cited 2023 May 30]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203565Orig1s019lbl.pdf
- LJ Scott; Ferric Carboxymaltose: A review in iron deficiency, [Revised on 2018] [Accessed on 30 May 2023], https://pubmed.ncbi.nlm.nih.gov/29532438/
- Amreen Naqash, Effectiveness and Safety of Ferric Carboxymaltose compared to iron sucrose in women with iron deficiency anemia, [Revised on 2018] [Accessed on 30 May 2023], https://pubmed.ncbi.nlm.nih.gov/29304848/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Archana Gupta
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 05 Aug 2026 | 06:49 AM (IST)
Want to know more?
Read Our Editorial Policy
